Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 5 (2023)

Management of methicillin resistant Staphylococcus aureus in canine dermal infection in Mizoram

Author(s):
Ankita Debnath, JB Rajesh, Kalyan Sarma, Lallawmzuali Ralte, TC Tolenkhomba, Hridayesh Prasad, Lalnuntluangi Hmar, Elone Lucy and Binipi Debbarma
Abstract:
Staphylococcus aureus infections show high rates of morbidity and mortality which can cause metastatic or complicated infections such as sepsis or infective endocarditis. Over the year’s MRSA has become a major nosocomial pathogen, highly prevalent throughout the world which has a serious health and global issue and may be transmitted via direct contact with contaminated surfaces. MRSA is responsible for most of the global health care related to S. aureus bacteraemia and compared with Methicillin sensitive S. aureus. MRSA infection is related with poorer clinical condition. A total of 22 numbers of MRSA infections were found in Mizoram among the 100 samples from dogs. MRSA positive dogs were treated with three antibiotics viz. doxycycline, clindamycin and sulfisoxazole according to zone of inhibition on antibiotic sensitivity test. Clinical score was decreased on day 21 after giving treatment with antibiotics along with supportive therapy. Among these antibiotics doxycycline was showing highest sensitivity.
Pages: 2829-2831  |  222 Views  144 Downloads


The Pharma Innovation Journal
How to cite this article:
Ankita Debnath, JB Rajesh, Kalyan Sarma, Lallawmzuali Ralte, TC Tolenkhomba, Hridayesh Prasad, Lalnuntluangi Hmar, Elone Lucy, Binipi Debbarma. Management of methicillin resistant Staphylococcus aureus in canine dermal infection in Mizoram. Pharma Innovation 2023;12(5):2829-2831.

Call for book chapter